Literature DB >> 22426326

A possible relationship of natural killer T cells with humoral immune response to 23-valent pneumococcal polysaccharide vaccine in clinical settings.

Tomomitsu Miyasaka1, Tetsuji Aoyagi, Binei Uchiyama, Kazunori Oishi, Toshinori Nakayama, Yuki Kinjo, Yoshitsugu Miyazaki, Hiroyuki Kunishima, Yoichi Hirakata, Mitsuo Kaku, Kazuyoshi Kawakami.   

Abstract

Pneumococcal polysaccharide vaccine (PPV), a type-2 thymus-independent antigen, induces the activation of B cells by directly triggering their antigen receptors. Although this type of antigen generally does not undergo class switching from IgM to IgG, PPV has been known to induce IgG2 in vaccinated subjects, which suggests the possible involvement of certain innate immune lymphocytes supporting the activation of B cells and their class switching. In the present study, we addressed the possibility that natural killer (NK) T cells are involved in Ab production caused by PPV. We measured serum levels of IgG against pneumococcal capsular polysaccharides and the numbers of CD4(+), CD8(+) and CD4(-)CD8(-) double negative (DN) invariant NKT (iNKT) cells and CD3(+)CD56(+) NKT cells in the peripheral blood before and after PPV injection. IgG was increased after PPV injection, peaking at 4 weeks after injection in serotypes 6B, 19F and 23F and at 3 months in serotype 14. Low responders, whose serum concentrations of IgG peaked at less than double their original levels, constituted 16%, 13%, 13% and 16% of vaccinated subjects with regard to serotypes 6B, 14, 19F and 23F, respectively. A significant positive correlation was detected between an increase in DN iNKT cells and the elevation of anti-serotype 14 IgG; in serotype 19F, DN iNKT cells were more markedly increased in responders than in low responders. These results suggest that DN iNKT cells may be involved in IgG production caused by vaccination against pneumococcal capsular polysaccharides.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426326     DOI: 10.1016/j.vaccine.2012.03.007

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Dectin-2-dependent NKT cell activation and serotype-specific antibody production in mice immunized with pneumococcal polysaccharide vaccine.

Authors:  Tomomitsu Miyasaka; Yukiko Akahori; Masahiko Toyama; Namiko Miyamura; Keiko Ishii; Shinobu Saijo; Yoichiro Iwakura; Yuki Kinjo; Yoshitsugu Miyazaki; Kazunori Oishi; Kazuyoshi Kawakami
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

Review 2.  Role of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcus.

Authors:  Stoyan Ivanov; Christophe Paget; François Trottein
Journal:  PLoS Pathog       Date:  2014-10-09       Impact factor: 6.823

3.  COVID-19 Specific Immune Markers Revealed by Single Cell Phenotypic Profiling.

Authors:  Francesca Sansico; Mattia Miroballo; Daniele Salvatore Bianco; Francesco Tamiro; Mattia Colucci; Elisabetta De Santis; Giovanni Rossi; Jessica Rosati; Lazzaro Di Mauro; Giuseppe Miscio; Tommaso Mazza; Angelo Luigi Vescovi; Gianluigi Mazzoccoli; Vincenzo Giambra
Journal:  Biomedicines       Date:  2021-11-29

4.  Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients.

Authors:  Magdalena Benda; Beatrix Mutschlechner; Hanno Ulmer; Claudia Grabher; Luciano Severgnini; Andreas Volgger; Patrick Reimann; Theresia Lang; Michele Atzl; Minh Huynh; Klaus Gasser; Ulf Petrausch; Peter Fraunberger; Bernd Hartmann; Thomas Winder
Journal:  Br J Haematol       Date:  2021-08-03       Impact factor: 8.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.